About Aarti Drugs Ltd.

Overview 

 

Aarti Drugs Ltd. (ADL) is an Indian pharma company, and part of the USD 650 million Aarti Group of Industries. Established in 1984, ADL is headquartered in Mumbai, Maharashtra, India. The company manufactures and sells vitamins, anti-arthritis, anti-fungal, antibiotic, ACE inhibitors and a wide range of anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs.

 

As of 31st March 2017, Arti Drugs Ltd. had:

  • 8 facilities located in Industrial MIDC Tarapur, Mahrashtra, about 120 km from Mumbai
  • 2 facilities located in Industrial GIDC Sarigam, Gujarat, about 160 km from Mumbai
  • A global footprint spanning across 94+ countries, including Brazil, Mexico, Netherlands and Spain
  • Multinational clients like Abbott, Sanofi-Aventis, Merck, Teva, Searle, Pfizer, Bayer and Clariant
  • Successfully commissioned a centralized state-of-the-art R&D centre at Tarapur MIDC, close to its manufacturing locations

 

Aarti Drugs Limited is listed on both Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

 

Aarti Drugs Limited at-a-glance

 

  • Sales Turnover (31 March, 2016) ~USD176 million

(~?1,166 crores)

  • Employees (31 March, 2016) 1072
  • Markets Served (countries) 94+
  • Manufacturing Facilities 10
  • Molecules Developed (last 6 yrs.) 30

 

 

Certifications

  • WHO-GMP
  • IDL
  • JAPAN Accreditation
  • TGA
  • COFEPRIS
  • ANVISA
  • EUGMP
  • USFDA
  • ISO-9001:2008

 

*Source: http://www.aartidrugs.co.in

 

History

The company has not shared this information

 

Milestones

 

    • 1984: Incorporated as a private limited company

  • 1991-92: Receives outstanding Performance in Export recognized by CHEMEXCIL

  • 1993: Gets listed on Stock Exchanges (BSE & NSE)

  • 1996: Amalgamation of RCIL, RCPL, MCPL, MPPL & EPCL

  • 1997: Achieves a turnover of ?100 Crore

  • 2001: Receives Outstanding Performance in Export Award from CHEMEXCIL

  • 2001: Receives Best Vendor Award from Organization of Pharmaceutical Product

  • 2005-06: Receives Customer Responsiveness Award from Avaya Global Connect

  • 2008: Receives approval for USFDA Plant

  • 2009: Receives Outstanding Performance in Export Award from PHARMEXCIL

  • 2010: Achieves a turnover of ?500 Crore

  • 2012: Receives Outstanding Performance in Latin American Export Award from

PHARMEXCIL

  • 2013: Receives Best Vendor of the Year Award from Abbott

  • 2014: Establishes a turnover of ?1000 Crore

 

BOARD OF DIRECTORS

 

  • Founder, Chairman & MD Mr. Prakash M. Patil
  • Managing Director Mr. Rashesh C. Gogri
  • Joint Managing Director Mr. Harshit M. Savla
  • Whole-time Director Mr. Harit P. Shah
  • Whole-time Director Mr. Uday M. Patil
  • Non-Executive Director Mr. Rajendra V. Gogri
  • Independent Director Mr. Ramdas M. Gandhi
  • Independent Director Dr. Vilas G. Gaikar
  • Independent Director Mr. Bhavesh R. Vora
  • Independent Director Prof. Krishnacharya G. Akamanchi
  • Independent Director Mr. Navin C. Shah
  • Independent Director Ms. Priti P. Savla

 

CONTACTS

 

CORPORATE OFFICE

Aarti Drugs Limited

Mahendra Industrial Estate, Ground Floor

Road No 29, Plot No 109-D

Sion (East), Mumbai-400 022

Maharashtra, India

 

Website: http://www.aartidrugs.co.in

Tel: +91 22 2401 9025 (30 LINES)

Fax: +91 22 2407 3462

+91 22 2407 0144

 

REGISTERED OFFICE

Aarti Drugs Limited

Plot No. N - 198

M.I.D.C., Tarapur, Village Pamtembhi

Taluka & Dist. Palghar-401 506

Maharashtra, India

 

 

 

 

 

 

 



Comment!
 
 






* Indicates mandatory field.
Please wait while comments are being sent...